MAZE
Maze Therapeutics, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:55 PM EST
31.23USD-4.874%(-1.60)709,739
After-hoursNov 18, 2026 4:22:30 PM EST
30.76USD-1.505%(-0.47)
MAZE Financials
In Q3 FY 2026 (ended ), Maze Therapeutics, Inc. Common Stock (MAZE) reported revenue of $0, net income of −$47.97M, operating cash flow of −$32.84M, and assets of $511.56M (filed ).
Loading financial statements…